{"created":"2023-05-15T14:51:34.923573+00:00","id":70511,"links":{},"metadata":{"_buckets":{"deposit":"4a9da159-1e12-4979-98cd-a063686381c8"},"_deposit":{"created_by":1,"id":"70511","owners":[1],"pid":{"revision_id":0,"type":"depid","value":"70511"},"status":"published"},"_oai":{"id":"oai:repo.qst.go.jp:00070511","sets":["10:28"]},"author_link":["692433","692435","692432","692437","692434","692430","692431","692436"],"item_10005_date_7":{"attribute_name":"発表年月日","attribute_value_mlt":[{"subitem_date_issued_datetime":"2011-09-01","subitem_date_issued_type":"Issued"}]},"item_10005_description_5":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"Caspase-7 (CASP7) is one of the effector caspases responsible for cleaving intracellular substrates involved in promoting the apoptotic phenotype. Interestingly a role for CASP7 in cell cycle progression at mitosis has also been suggested. Additionally, CASP7 polymorphisms are associated with increased risk for several types of cancer such as breast cancer, endometrial cancer and lung cancer. However little is known about the association of CASP7 with individual radiosensitivity. Therefore, in this study, we analyzed the association of functional polymorphisms in CASP7 with the risk of an adverse reaction in the intestinal tract after radiotherapy.\nA total of 208 cervical cancer patients who had been treated with pelvic radiotherapy were genetically analyzed. Early gastrointestinal reactions were graded using the National Cancer Institute Common Toxicity Criteria, and patients were dichotomized into a lower-grade (LG) group (! Grade = 0 or 1, n = 150) and a higher-grade (HG) group (Grade = 2 or 3, n = 58). Three SNPs with minor allele frequencies of more than 5% in our healthy control samples, rs12415607 (C-1222A), rs11593766 (T398G, Asp4Glu), and rs2227310 (C1151G, Asp255Glu), were subjected to genotype and haplotype analyses in the cervical cancer patients.\nAmong these 3 SNPs, only rs11593766 was found to be associated with a risk of adverse reaction in the intestinal tract. The frequency of the G allele of this SNP was significantly higher in the HG group (18%) than in the LG group (9%; odds ratio [OR], 2.24; 95% confidence interval [CI], 1.18-4.21; P = 0.016). The GG and TG genotypes of rs11593766 were significantly associated with an increased risk of adverse reaction in the intestinal tract (OR, 2.15; 95% CI, 1.04-4.44; P = 0.038). No significant haplotype including rs11593766 was detected. Diplotypes of NPAT-ATM and AURKA have also been reported to con t! ribute to the risk of adverse intestinal reaction after radiotherapy, and we found that patients who had two or more of the NPAT-ATM, AURKA or CASP7 risk genotypes showed higher risk than other patients (OR, 3.60; 95% CI, 1.83-7.19; P = 0.00007).\nOur results suggest that the rs11593766 GG and TG genotypes (Glu/Glu or Asp/Glu) of CASP7 might contribute to the individual risk of adverse intestinal reaction after radiotherapy.","subitem_description_type":"Abstract"}]},"item_10005_description_6":{"attribute_name":"会議概要（会議名, 開催地, 会期, 主催者等）","attribute_value_mlt":[{"subitem_description":"14th International Congress of Radiation Research(ICRR’2011)","subitem_description_type":"Other"}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"metadata only access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_14cb"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Imai, Takashi"}],"nameIdentifiers":[{"nameIdentifier":"692430","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Ishikawa, Atsuko"}],"nameIdentifiers":[{"nameIdentifier":"692431","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Suga, Tomo"}],"nameIdentifiers":[{"nameIdentifier":"692432","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Otsuka, Yoshimi"}],"nameIdentifiers":[{"nameIdentifier":"692433","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"今井 高志","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"692434","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"石川 敦子","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"692435","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"菅 智","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"692436","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"荘司 好美","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"692437","nameIdentifierScheme":"WEKO"}]}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"conference object","resourceuri":"http://purl.org/coar/resource_type/c_c94f"}]},"item_title":"Association of the caspase-7 Asp4Glu polymorphism with increased risk of adverse reaction in the gastrointestinal tract after pelvic radiotherapy in cervical cancer patients","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Association of the caspase-7 Asp4Glu polymorphism with increased risk of adverse reaction in the gastrointestinal tract after pelvic radiotherapy in cervical cancer patients"}]},"item_type_id":"10005","owner":"1","path":["28"],"pubdate":{"attribute_name":"公開日","attribute_value":"2011-09-06"},"publish_date":"2011-09-06","publish_status":"0","recid":"70511","relation_version_is_last":true,"title":["Association of the caspase-7 Asp4Glu polymorphism with increased risk of adverse reaction in the gastrointestinal tract after pelvic radiotherapy in cervical cancer patients"],"weko_creator_id":"1","weko_shared_id":-1},"updated":"2023-05-15T20:02:05.457369+00:00"}